Canine T cells transduced with a herpes simplex virus thymidine kinase gene: A model to study effects on engraftment and control of graft-versus- host disease

Transplantation

Volumn 66, Issue 4, 1998, Pages 540-544

  Georges, George E ^a,b   Storb, Rainer ^a,b   Brunvand, Mark W ^a,c   Kiem, Hans Peter ^a,b   Moore, Peter F ^d   Malik, Punam ^e   Ennist, David ^f   Nash, Richard A ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Rocky Mountain Cancer Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOG; GENETIC TRANSDUCTION; GIBBON LEUKEMIA VIRUS; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DOGS; SIMPLEXVIRUS; T-LYMPHOCYTES, CYTOTOXIC; THYMIDINE KINASE; TRANSDUCTION, GENETIC;

EID: 0032572762     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808270-00023     Document Type: Article

References (22)

1. Martin PJ, Hansen JA, Buckner CD, et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66: 664.
2. Storb R, Thomas ED. Graft-versus-host disease in dog and man: the Seattle experience. Immunol Rev 1985; 88: 215.
3. Schwarzinger I, Raff RF, Flowers M, et al. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow. Bone Marrow Transplant 1994; 13: 303.
4. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 1991; 65: 2220.
5. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6: 2895.
6. Tiberghien P, Reynolds CW, Keller J, et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 1994; 84: 1333.
7. Malik P, McQuiston SA, Yu XJ, et al. Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J Virol 1997; 71: 1776
8. Miller DG, Edwards RH, Miller AD. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci USA 1994; 91: 78.
9. Bunnell BA, Muul LM, Donahue RE, Blaese RM, Morgan RA. High efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 1995; 92: 7739.
10. Miller DG, Miller AD. A family of retroviruses that utilize related phosphate transporters for cell entry. J Virol 1994; 68: 8270.
11. Culver K, Cornetta K, Morgan R, et al. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA 1991; 88: 3155.
12. Moore PF, Rossitto PV, Danilenko DM, Wielenga JJ, Raff RF, Severns E. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens 1992; 40: 75.
13. Appelbaum FR, Meyers JD, Deeg HJ, Graham T, Schuening F, Storb R. Toxicity trial of prophylactic 9-[2-hydroxy-1-(hydroxymethy)ethoxymethyl] guanine (ganciclovir) after marrow transplantation in dogs. Antimicrob Agents Chemother 1988; 32: 271.
14. Deeg HJ, Storb R, Shulman HM, Weiden PL, Graham TC, Thomas ED. Engraftment of DLA-nonidentical unrelated canine marrow after high-dose fractionated total body irradiation. Transplantation 1982; 33: 443.
15. Martin PJ. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism. Blood 1996; 88: 962.
16. + T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 76: 418.
17. Drobyski WR, Ash RC, Casper JT, et al. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 1980.
18. Cohen JL, Boyer O, Salomon B, et al. Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes. Blood 1997; 89: 4636.
19. Helene M, Lake-Bullock V, Bryson JS, Jennings CD, Kaplan AM. Inhibition of graft-versus-host disease: use of a T cell-controlled suicide gene. J Immunol 1997; 158: 5079.
20. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719.
21. Riddell SR, Elliott MJ, Lewinsohn A, et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 1996; 2: 216.
22. Munshi NC, Govindarajan R, Drake R, et al. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir. Blood 1997; 89: 1334.